Studying multiple protein profiles over time to assess biomarker validity

References

• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics1(11), 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Adkins JN, Varnum SM, Auberry KJ et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics1(12), 947–955 (2002).
   PubMed Web of Science ®Google Scholar
• Pieper R, Gatlin CL, Makusky AJ et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics,3(7), 1345–1364 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Polanski M, Pieper R et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics,3(4), 311–326 (2004).
   PubMed Web of Science ®Google Scholar
• Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature,425(6961), 905 (2003).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Liotta LA. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clin. Chem.49(4), 533–534 (2003).
   PubMed Web of Science ®Google Scholar
• Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis21(6), 1164–1177 (2000).
   PubMed Web of Science ®Google Scholar
• Adam BL, Qu Y, Davis JW et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res.62(13), 3609–3614 (2002).
   PubMed Web of Science ®Google Scholar
• Honda K, Hayashida Y, Umaki T et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res.65(22), 10613–10622 (2005).
   PubMedGoogle Scholar
• Jacquemier J, Ginestier C, Rougemont J et al. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res.65(3), 767–779 (2005).
   PubMed Web of Science ®Google Scholar
• Li Y, Dang TA, Shen J et al. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Proteomics6(11), 3426–3435 (2006).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359(9306), 572–577 (2002).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol.15(1), 24–30 (2004).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ornstein DK, Liotta LA. Clinical proteomics: applications for prostate cancer biomarker discovery and detection. Urol. Oncol.22(4), 322–328 (2004).
   PubMedGoogle Scholar
• Petricoin EF III, Ornstein DK, Paweletz CP et al. Serum proteomic patterns for detection of prostate cancer. J. Natl Cancer Inst.94(20), 1576–1578 (2002).
   PubMed Web of Science ®Google Scholar
• Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ. Proteomic patterns: their potential for disease diagnosis. Mol. Cell. Endocrinol.230(1–2), 95–106 (2005).
   PubMed Web of Science ®Google Scholar
• Bjornstad A, Larsen BK, Skadsheim A, Jones MB, Andersen OK. The potential of ecotoxicoproteomics in environmental monitoring: biomarker profiling in mussel plasma using proteinchip array technology. J . Toxicol. Environ. Health A.69(1), 77–96 (2006).
   PubMed Web of Science ®Google Scholar
• Guerreiro N, Gomez-Mancilla B, Charmont S. Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid. Proteome Sci.4(1), 7 (2006).
   PubMedGoogle Scholar
• Haubitz M, Wittke S, Weissinger EM et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int.67(6), 2313–2320 (2005).
   PubMed Web of Science ®Google Scholar
• Liao H, Wu J, Kuhn E et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum.50(12), 3792–3803 (2004).
   PubMed Web of Science ®Google Scholar
• Poon TC, Hui AY, Chan HL et al. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin. Chem.51(2), 328–335 (2005).
   PubMed Web of Science ®Google Scholar
• Streckfus CF, Bigler LR, Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J. Oral Pathol. Med.35(5), 292–300 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wroblewski M, Hertz MI et al. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics6(3), 1001–1010 (2006).
   PubMed Web of Science ®Google Scholar
• Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl Cancer Inst.97(4), 307–309 (2005).
   PubMed Web of Science ®Google Scholar
• Check E. Proteomics and cancer: running before we can walk? Nature429(6991), 496–497 (2004).
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin. Chem.49(8), 1272–1275 (2003).
   PubMed Web of Science ®Google Scholar
• Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing data sets from different experiments. Bioinformatics (2004).
   Google Scholar
• Hortin GL. The MALDI TOF Mass spectrometric view of the plasma proteome and peptidome. Clin. Chem.52(7), 1223-1237 (2006).
   PubMed Web of Science ®Google Scholar
• Fraser CG. Inherent biological variation and reference values. Clin. Chem. Lab. Med.42, 758–764 (2004).
   PubMed Web of Science ®Google Scholar
• Nelsestuen GL, Zhang Y, Martinez MB et al. Plasma protein profiling: unique and stable features of individuals. Proteomics5, 4012–4024 (2005).
   PubMed Web of Science ®Google Scholar
• Abdul-Salam VB, Paul GA, Ali JO et al. Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics6(7), 2286–2294 (2006).
   PubMedGoogle Scholar
• Stanley BA, Gundry RL, Cotter RJ, Van Eyk JE. Heart disease, clinical proteomics and mass spectrometry. Dis. Markers20(3), 167–178 (2004).
   PubMed Web of Science ®Google Scholar
• Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J. Lipid Res.40(3), 543–555 (1999).
   PubMed Web of Science ®Google Scholar
• Bergen HR III, Zeldenrust SR, Butz ML et al. Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin. Chem.50(9), 1544–1552 (2004).
   PubMed Web of Science ®Google Scholar
• van der Poll T, van Deventer S. Endotoxemia in healthy subjects as a human model of inflammation. In: The Immune Response in the Critically Il. Cohen J (Ed.), Springer Verlag, Germany, 335–357 (1999)
   Google Scholar
• Moore F. Complement Pier GB, Wetzler LM (Eds). ASM Press, WA, USA (2004).
   Google Scholar
• Walport MJ. Complement. First of two parts. N. Engl. J. Med.344(14), 1058–1066 (2001).
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. Second of two parts. N. Engl. J. Med.344(15), 1140–1144 (2001).
   PubMed Web of Science ®Google Scholar
• Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Lett.537(1–3), 166–170 (2003).
   PubMed Web of Science ®Google Scholar
• Ferrara JL, Levine JE. Graft-versus-host disease in the 21st century: new perspectives on an old problem. Semin. Hematol.43(1), 1–2 (2006).
   PubMedGoogle Scholar
• Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am. J. Respir. Crit. Care Med.166(4), 440–444 (2002).
   PubMed Web of Science ®Google Scholar
• Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics5, 1705–1713 (2005).
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int.62(4), 1461–1469 (2002).
   PubMed Web of Science ®Google Scholar
• Pieper R, Gatlin CL, McGrath AM et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics4(4), 1159–1174 (2004).
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, Malasit P. Renal and urinary proteomics: current applications and challenges. Proteomics5(4), 1033–1042 (2005).
   PubMed Web of Science ®Google Scholar
• Jurgens M, Appel A, Heine G et al. Towards characterization of the human urinary peptidome. Comb. Chem. High Throughput Screen.8(8), 757–765 (2005).
   PubMed Web of Science ®Google Scholar
• Celis JE, Wolf H, Ostergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis21(11), 2115–2121 (2000).
   PubMedGoogle Scholar
• Sarto C, Deon C, Doro G et al. Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase. Proteomics1(10), 1288–1294 (2001).
   PubMedGoogle Scholar
• Clarke W, Silverman BC, Zhang Z et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg.237(5), 660–665 (2003).
   PubMed Web of Science ®Google Scholar
• Schaub S, Rush D, Wilkins J et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol.15(1), 219–227 (2004).
   PubMed Web of Science ®Google Scholar